Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 41,600 | 13,520 | 18,330 | 19,170 | 9,420 |
| Other Working Capital | -24,800 | -13,560 | -24,510 | -42,770 | -27,280 |
| Other Operating Activity | 5,030 | 5,850 | 2,450 | 810 | -2,590 |
| Operating Cash Flow | $21,830 | $5,810 | $-3,730 | $-22,790 | $-20,450 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -166,170 | -1,060 | -330 | 7,990 | 8,910 |
| Other Investing Activity | -22,570 | -148,350 | -86,810 | 3,930 | -10,190 |
| Investing Cash Flow | $-188,740 | $-149,410 | $-87,140 | $11,920 | $-1,280 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 180,700 | 184,200 | 183,190 | 27,010 | 12,700 |
| Financing Cash Flow | $180,700 | $184,200 | $183,190 | $27,010 | $12,700 |
| Exchange Rate Effect | 0 | 800 | -2 | -260 | -5 |
| Beginning Cash Position | 29,920 | 30,900 | 30,880 | 14,060 | 14,020 |
| End Cash Position | 48,380 | 72,300 | 123,190 | 29,940 | 4,990 |
| Net Cash Flow | $18,450 | $41,400 | $92,310 | $15,870 | $-9,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | 21,830 | 5,810 | -3,730 | -22,790 | -20,450 |
| Free Cash Flow | 21,830 | 5,810 | -3,730 | -22,790 | -20,450 |